Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase NA 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

OTHER 23 OTHER_GOV 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 687 Breast Neoplasms 585 Neoplasms 468 Colorectal Neoplasms 300 Prostatic Neoplasms 263 Neoplasm Metastasis 257 Melanoma 242 Ovarian Neoplasms 228 Recurrence 216 Lung Neoplasms 203 Multiple Myeloma 196 Lymphoma, Non-Hodgkin 155 Pancreatic Neoplasms 154 Leukemia, Myeloid, Acute 142 Carcinoma, Hepatocellular 141 Stomach Neoplasms 137 Lymphoma 131 Carcinoma, Renal Cell 128 Glioblastoma 118 Squamous Cell Carcinoma of Head and Neck 113 Head and Neck Neoplasms 113 Lymphoma, Follicular 106 Leukemia, Lymphocytic, Chronic, B-Cell 99 Small Cell Lung Carcinoma 96 Lymphoma, Large B-Cell, Diffuse 96 Leukemia 96 Brain Neoplasms 91 Carcinoma 82 Uterine Cervical Neoplasms 77 Triple Negative Breast Neoplasms 73

Interventions

rucaparib 1 relatlimab 1 linrodostat 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × INDUSTRY × Advanced Gastric Cancer × Clear all

NCT02935634 2023-06-09

FRACTION-GC

Bristol-Myers Squibb

Phase 2 Completed

190 enrolled 25 charts

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡